Aegis Sciences Corporation Doubles Capacity for Coronavirus Disease 2019 (COVID-19) Testing
27 avr. 2020 09h40 HE
|
Aegis Sciences Corporation
NASHVILLE, Tenn., April 27, 2020 (GLOBE NEWSWIRE) -- Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting...
Aegis Sciences Corporation Launches Test for Coronavirus Disease 2019 (COVID-19)
13 avr. 2020 09h54 HE
|
Aegis Sciences Corporation
NASHVILLE, Tenn., April 13, 2020 (GLOBE NEWSWIRE) -- Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting...
New Research Shows How Diagnostic Testing Can Advance the Identification and Treatment of Harmful Drug-Drug Interactions
05 déc. 2018 09h55 HE
|
Aegis Sciences Corporation
NASHVILLE, Tenn., Dec. 05, 2018 (GLOBE NEWSWIRE) -- Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative testing and consulting services to providers,...
New Research Reveals the Prevalence of Drug-Drug Interactions and the Economic Impact on the Healthcare System
05 nov. 2018 14h00 HE
|
Aegis Sciences Corporation
Studies show an alarming prevalence of concurrent ingestion of interacting substances by patients and that providing physicians with clear, objective information leads to a reduction of interactions...
Aegis Sciences Launches New Medication Adherence Tool for Behavioral Healthcare
12 sept. 2018 14h09 HE
|
Aegis Sciences Corporation
NASHVILLE, Tenn., Sept. 12, 2018 (GLOBE NEWSWIRE) -- Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative testing and consulting services to providers, today...
Dr. Elaine Jeter Joins Aegis Sciences Corporation as Senior Medical Policy Advisor
24 avr. 2018 12h55 HE
|
Aegis Sciences Corporation
NASHVILLE, Tenn., April 24, 2018 (GLOBE NEWSWIRE) -- Aegis Sciences Corporation, a leading healthcare sciences and forensic toxicology laboratory, is pleased to announce that Dr. Elaine Jeter has...